Imagia’s mission is to detect and quantify cancer changes early. When it matters.
Cancer. It's about time
Despite systematic imaging and new genetic testing, tumor changes are often detected too late to improve cancer patient outcomes.
What we do
Our Artificial Clinical Intelligence Platform enables us to provide critical information and timely imaging insights for primary tumors and metastasis for each cancer patient thus personalizing their cancer care continuum.
Deep Radiomics™ — uniting radiomics and deep learning — utilizes existing routine clinical imaging data to discover robust imaging biomarkers that predict cancer patient outcomes.
Artificial Clinical Intelligence
Imagia has built an end-to-end Artificial Intelligence (AI) driven imaging biomarker discovery and validation platform upon advances in unsupervised learning and AI safety.
Imagia’s Deep Radiomics solution uniquely leverages advances in deep learning to address the specific AI challenges of patient data hetero-modality and disease progression.